Ryan Troup

Ryan Troup is the Editor in Chief of Wealthy VC. Ryan has 15+ years of investing experience. X | Email
Top Stories

Nvidia Stock Skyrockets on Strong Earnings and AI-Fueled “Guidance For the Ages” (VIDEO)

Last Updated: After Releasing Strong Q1 Earnings and Issuing an AI-Fueled Blowout Q2 Forecast, Nvidia Has Wall Street Buzzing Let’s…

Read More »
Tech

XTM Plans Acquisition of World-Class Earned Wage Access Company QRails

XTM Inc. (CSE: PAID) (OTCQB: XTMIF) (FSE: 7XT), a Miami and Toronto-based Fintech creator of disruptive payment innovations and mobile…

Read More »
Top Stories

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

Last Updated: Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the…

Read More »
Top Stories

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest…

Read More »
Top Stories

XTM and CloudMD Join Forces to Offer Virtual Health Care and Mental Health Support to Service Workers in its Today Program™

XTM Inc. (CSE: PAID) (OTCQB: XTMIF) (FSE: 7XT), a Miami and Toronto-based Fintech creator of disruptive payment innovations and mobile…

Read More »
Top Stories

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest…

Read More »
Top Stories

U.S. Banking Crisis Could See a Staggering 190 Banks Collapse According to a New Study (VIDEO)

Last Week, First Republic Bank Became the Third Bank This Year to Collapse, and Now PacWest Bancorp is Teetering on…

Read More »
Top Stories

ELEVAI Labs to Accelerate and Expand its Work With Stem Cell-Derived Exosomes After Securing New Research Partnership and Non-Repayable Grant

ELEVAI Labs, a medical aesthetic biotechnology company specializing in physician-dispensed skincare, reported today that it secured a stem cell exosome…

Read More »
Top Stories

Fintech Growth Stock XTM Reports Triple-Digit Revenue Growth in 2022

XTM (CSE: PAID) (OTCQB: XTMIF) (FSE: 7XT), a Miami and Toronto-based fintech creator of disruptive payment innovations and staff management…

Read More »
Top Stories

Is Tesla Stock a Buy Following Double-Digit Decline on Disappointing Earnings? (VIDEO)

Shares of TSLA Stock Plummeted as Much as 10% Today in Reaction to the Company’s Poor Earnings Report on Wednesday…

Read More »
Back to top button